Physician profile
George Agapios
NPI 1447269386
$1,502.94
in general payments reported to CMS, 2019-2025
19 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $125 · 2024: $482 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $728.10 | 2019-2025 | Breztri, Airsupra |
| Exact Sciences Corporation | $117.19 | 2025 | The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $105.68 | 2019 | |
| Verona Pharma, INC. | $102.88 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $56.44 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.97 | 2019 | |
| Pfizer INC. | $52.67 | 2019 | |
| Braintree Laboratories, INC. | $47.42 | 2019 | |
| Scilex Pharmaceuticals INC. | $39.92 | 2019 | |
| Amgen INC. | $35.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $34.10 | 2019 | |
| Sunovion Pharmaceuticals INC. | $29.87 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.42 | 2019 | |
| Inspire Medical Systems, INC. | $16.33 | 2025 | Inspire |
| Novartis Pharmaceuticals Corporation | $12.66 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.43 | 2019 | |
| Merck Sharp & Dohme LLC | $12.02 | 2019 | |
| Novo Nordisk INC | $11.55 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Agapios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.